Ruiz M et al. |
High-Density Lipoprotein-Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1. |
2017 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:27879252
|
Michaud MD et al. |
Sphingosine-1-phosphate: a novel nonhypoxic activator of hypoxia-inducible factor-1 in vascular cells. |
2009 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:19423865
|
Kontush A et al. |
Preferential sphingosine-1-phosphate enrichment and sphingomyelin depletion are key features of small dense HDL3 particles: relevance to antiapoptotic and antioxidative activities. |
2007 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:17569880
|
Kim YM et al. |
G(alpha)12/13 induction of CYR61 in association with arteriosclerotic intimal hyperplasia: effect of sphingosine-1-phosphate. |
2011 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:21212405
|
Tatematsu S et al. |
Endothelial lipase is a critical determinant of high-density lipoprotein-stimulated sphingosine 1-phosphate-dependent signaling in vascular endothelium. |
2013 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:23723371
|
Kimura T et al. |
High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors. |
2003 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:12775579
|
Shimizu T et al. |
Sphingosine-1-phosphate receptor 3 promotes neointimal hyperplasia in mouse iliac-femoral arteries. |
2012 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:22308044
|
Hao J et al. |
The interaction between C5a and sphingosine-1-phosphate in neutrophils for antineutrophil cytoplasmic antibody mediated activation. |
2014 |
Arthritis Res. Ther. |
pmid:25000985
|
Kamradt T and Frey O |
Arthritis: where are the T cells? |
2010 |
Arthritis Res. Ther. |
pmid:20537200
|
Stradner MH et al. |
Sphingosine 1-phosphate counteracts the effects of interleukin-1β in human chondrocytes. |
2013 |
Arthritis Rheum. |
pmid:23666803
|
Kitano M et al. |
Sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: regulation of synovial proliferation and inflammatory gene expression. |
2006 |
Arthritis Rheum. |
pmid:16508938
|
Callihan P et al. |
Convergent regulation of neuronal differentiation and Erk and Akt kinases in human neural progenitor cells by lysophosphatidic acid, sphingosine 1-phosphate, and LIF: specific roles for the LPA1 receptor. |
2014 |
ASN Neuro |
pmid:25424429
|
Togame H et al. |
Development of a simple and robust assay to screen for inhibitors of sphingosine kinases. |
2007 |
Assay Drug Dev Technol |
pmid:17477830
|
Potì F et al. |
SKI-II--a sphingosine kinase 1 inhibitor--exacerbates atherosclerosis in low-density lipoprotein receptor-deficient (LDL-R-/-) mice on high cholesterol diet. |
2015 |
Atherosclerosis |
pmid:25801013
|
Muehlich S et al. |
Induction of connective tissue growth factor (CTGF) in human endothelial cells by lysophosphatidic acid, sphingosine-1-phosphate, and platelets. |
2004 |
Atherosclerosis |
pmid:15262182
|
Tamama K et al. |
High-density lipoprotein inhibits migration of vascular smooth muscle cells through its sphingosine 1-phosphate component. |
2005 |
Atherosclerosis |
pmid:15585196
|
Zhang B et al. |
Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins. |
2005 |
Atherosclerosis |
pmid:15585219
|
Bosteen MH et al. |
Effects of apolipoprotein M in uremic atherosclerosis. |
2017 |
Atherosclerosis |
pmid:28866363
|
Karuna R et al. |
Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism. |
2011 |
Atherosclerosis |
pmid:21944699
|
Denimal D et al. |
Significant abnormalities of the HDL phosphosphingolipidome in type 1 diabetes despite normal HDL cholesterol concentration. |
2015 |
Atherosclerosis |
pmid:26142685
|